Table 1.
Group | None‐LD group (n=79) | LD group (n=41) | P value |
---|---|---|---|
Age | 41.6±11.4 | 38.1±10.9 | .328a |
Gender | |||
Male | 20 | 11 | .858b |
Female | 59 | 30 | |
ALT (0~40 U/L) | 25.2±6.5 | 68.4±35.7 | <.001a |
AST (29~35 U/L) | 30.0±7.0 | 50.5±19.1 | <.001a |
GGT (3~50 U/L) | 37.0±20.1 | 62.9±27.2 | <.001a |
TBIL (3.4~17.1 μmol/L) | 14.7±5.3 | 19.9±8.2 | <.001a |
ALP (40~150 U/L) | 127.3±58.7 | 171.2±57.1 | <.001a |
TP (60~80 g/L) | 60.4±1.8 | 54.8±5.2 | <.001a |
ALB (35~55 g/L) | 38.7±2.1 | 33.7±2.9 | <.001a |
FT3 (3~9 pmol/L) | 14.3±6.8 | 16.8±8.9 | .089a |
FT4 (9~25 pmol/L) | 52.6±20.7 | 59.6±18.9 | .073a |
TSH (0.04‐2.5 mIU/L) | 0.016±0.003 | 0.015±0.004 | .126a |
GD, Graves’ disease; none‐LD group, GD patients without LD were included; LD group, GD patients with LD were included; ALT, Alanine aminotransferase; AST, Aspartate transaminase; GGT: Gamma‐glutamyl transferase; TBIL, Total bilirubin; ALP, Alkaline phosphatase; TP, Total protein; ALB, Serum albumin; FT3, Free triiodothyronine; FT4, Free thyroxine; TSH, thyroid stimulating hormone.
Represents that P value was related to none‐LD and LD group and was analyzed by Mann‐Whitney test.
Represents that P value was related to none‐LD and LD group and was analyzed by Chi‐square test.